In spite of the frequency of the molecular alterations of PI3K in oesophageal cancer, the PI3K-AKT-mTOR pathway has received less attention than EGFR or VEGF in ESCC and EAC. The gene discussed is AKT1; the disease is carcinoma of esophagus.